Human medicines European public assessment report (EPAR): Stribild, elvitegravir,cobicistat,emtricitabine,tenofovir disoproxil, Date of authorisation: 24/05/2013, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Wyost, denosumab, Date of authorisation: 17/05/2024, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR): Instanyl, fentanyl, Date of authorisation: 20/07/2009, Revision: 40, Status: Authorised

Human medicines European public assessment report (EPAR): Ferriprox, deferiprone, Date of authorisation: 25/08/1999, Revision: 33, Status: Authorised

Human medicines European public assessment report (EPAR): Humira, adalimumab, Date of authorisation: 08/09/2003, Revision: 95, Status: Authorised

EMA closed on 15 August for Assumption Day

Human medicines European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously Chenodeoxycholic acid sigma-tau), chenodeoxycholic acid, Date of authorisation: 10/04/2017, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Enbrel, etanercept, Date of authorisation: 02/02/2000, Revision: 76, Status: Authorised

List of changes to combined Veterinary Dictionary for Drug Regulatory Activities (VeDDRA) list of clinical terms for reporting suspected adverse events in animal and humans to veterinary medicinal products for 2025

Human medicines European public assessment report (EPAR): Dazublys, trastuzumab, Date of authorisation: 30/06/2025, Status: Authorised